Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-23

Clinical Trial Update: Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing liposomal doxorubicin versus observation or cyclophosphamide and methotrexate in older women after breast cancer surgery was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liposomal doxorubicin (doxorubicin liposomal)

Snippet

Sponsor: ETOP IBCSG Partners Foundation | Conditions: Breast Cancer | Phase 3 | Status: TERMINATED